Loading...
Market
How will Septerna Inc.'s market segment growth compare to biotech industry average in 2024?
2
Resolution / Starting Odds
Above industry average • 25%
Equal to industry average • 25%
Below industry average • 25%
Data unavailable • 25%
Industry reports and financial analysis
Story
Goldman Sachs-backed Septerna Inc. Raises $288 Million in IPO, Valuation Reaches $970 Million After 31% Surge on Nasdaq Debut
Oct 25, 2024, 01:39 PM
Septerna Inc., a Goldman Sachs-backed biotechnology company, has successfully completed its upsized initial public offering (IPO), raising $288 million. The company offered 16 million shares at a price of $18 each, an increase from the previously proposed 15.27 million shares. Following its debut on the Nasdaq, Septerna's shares surged nearly 31%, leading to a market valuation of approximately $970 million. The IPO reflects positive investor sentiment in the biotech sector, particularly for companies focused on G protein-coupled receptors (GPCRs), which are crucial for developing new therapies. The funds raised will support Septerna's pipeline of GPCR drugs, addressing unmet patient needs.
View original story
Similar markets
No change • 25%
Improved by 1-5 ranks • 25%
Improved by 6-10 ranks • 25%
Improved by more than 10 ranks • 25%
Outperform • 25%
Match • 25%
Underperform • 25%
Significantly Underperform • 25%
Top 5 • 33%
Top 10 • 33%
Below top 10 • 33%
Significantly outperform • 25%
Slightly outperform • 25%
Match sector performance • 25%
Underperform • 25%
0-10% • 25%
10-20% • 25%
20-30% • 25%
More than 30% • 25%
Outperforms sector • 25%
Performs similarly to sector • 25%
Underperforms sector • 25%
No significant change • 25%
Less than 5% growth • 25%
5% to 10% growth • 25%
10% to 20% growth • 25%
More than 20% growth • 25%
Top 5 • 25%
Top 10 • 25%
Top 20 • 25%
Below Top 20 • 25%
Increase by more than 5% • 25%
Increase by 1-5% • 25%
No significant change • 25%
Decrease • 25%
Tech sector outperforms the market • 25%
Tech sector underperforms the market • 25%
Tech sector performs similarly to the market • 25%
Mixed performance within tech sector • 25%
Top 50 • 25%
Top 100 • 25%
Top 200 • 25%
Below Top 200 • 25%